Atrium Therapeutics
RNA
Atrium Therapeutics (RNA) news
Recent news
Trading released/resumed: (Attiu) Reason not available
Trading in the security known as "Attiu" has been temporarily halted, with the resumption date and reason for the halt not currently available to the public. Trading pauses are typically implemented to address market irregularities, ensure fair trading practices, or allow for dissemination of…
AInvest Wire · 4h agoAtrium Therapeutics - Net proceeds and existing cash expected to fund operations through 2028
AInvest Wire · 5d agoAtrium Therapeutics announces $50 million private placement
AInvest Wire · 5d agoAtrium Therapeutics, Inc.: H.C. Wainwright initiates coverage with buy rating and target price $25
AInvest Wire · Aug 6, 2026Atrium Therapeutics - first participant expected by end of 2026; initial data anticipated second half 2027
AInvest Wire · Jul 14, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.